Advertisement
Mr. DeWinter brings over 30 years of finance, management and transactionalexperience to the Apollo team, including 10 years at Wahlco EnvironmentalSystems, Inc., which he joined in 1990 as chief financial officer and vicepresident. He was instrumental in Wahlco's 1990 initial public offering on theNew York Stock Exchange. Prior to joining Apollo, Mr. DeWinter most recentlyserved as chief financial officer of Bridgetech Holdings International, Inc.,a company focused primarily on the business of facilitating the transfer ofmedical drugs, devices and diagnostics from the United States to China andother international locations. He has also served as CFO of Capital PacificHomes, Inc., a Newport Beach-based diversified residential and commercial realestate development company and Vilink Communications, Inc., a manufacturer offiber-optic communications equipment. He also served in numerous financialpositions with Global Marine, Inc., a NYSE offshore oil drilling andexploration company for 8 years and later as vice president of Houston-basedChallenger Minerals, Inc, an oil and gas exploration company.
Advertisement
Mr. DeWinter holds a BA in Economics from Carleton College and an MBA fromthe Wharton School at the University of Pennsylvania.
"Noel has tremendous experience in the financial and operational realms,which will be invaluable to us as we build a robust business with long-termprospects," stated Warren Hosseinion, M.D., Chief Executive Officer of ApolloMedical Holdings, Inc.
"I am excited to join a pioneering company in a truly dynamic, new sectorof the healthcare market," stated DeWinter. "I think Apollo has tremendouspotential. I look forward to working with the rest of the management team aswe implement Apollo's financial and operational strategies."
About Apollo Medical Holdings, Inc.
Apollo is a leading provider of management services to medical groups thatprovide comprehensive hospital-based medical services. The company intends tocapitalize on the growing market for hospital-based physicians, such ashospitalists, or physicians with expertise in hospital medicine. There are4900 acute care hospitals in the U.S., with over 35 million annual admissions.Total U.S. spending on hospital care is over $650 billion, and is expected toincrease to $1.3 trillion by 2016. There are tremendous inefficiencies in thedelivery of inpatient care and a high rate of hospital errors. Both of theseare drivers for the growth of hospital-based medicine. Apollo and itsaffiliated medical groups have proven expertise in providing excellent andefficient care to hospitalized patients.
Safe Harbor Statement
Under the Private Securities Litigation Reform Act of 1995: Except forhistorical information contained herein, the statements in this news releaseare forward-looking statements that are made pursuant to the safe harborprovisions of the Private Securities Act of 1995. Forward-looking statementsinvolve known and unknown risks and uncertainties, which may cause a company'sactual results, performance and achievement in the future to differ materiallyfrom forecasted results, performance and achievement. These risks anduncertainties are described in the Company's periodic filings with theSecurities and Exchange Commission. The Company undertakes no obligation topublicly release the results of any revisions to these forward-lookingstatements that may be made to reflect events or circumstances after the datehereof, or to reflect the occurrence of unanticipated events or changes in theCompany's plans or expectations.
SOURCE Apollo Medical Holdings
